1. National Cancer Institute Monographs 46:133-137, 1977
2. Lancet 1:987, 1979
3. Lancet 2:141-142, 1981
4. Journal of Medicine 13:49-69, 1982
5. Protides of Biological Fluids 30:337-352, 1983
6. Protides of Biological Fluids 31:739-747, 1984
7. Cancer Detection and Prevention 8:Number 5/6, 551, 1985
8. Cancer Detection and Prevention 11:Number 1/2, 85, 1987
9. "In Vitro production of the general transformation antibody related to survival in human cancer patients: Antimalignin Antibody" Cancer Det. and Prev. 12:313-320, 1988
10. "Malignin antibody and early malignancy," the Lancet 337-977, 1991
11. "Malignin antibody returns to normal after successful treatment of breast cancer", Cancer Detection and Prevention 17(1):180, 1993
12. "Comparison of Antimalignin with other markers for early detection and surrogate endpoint use in chemoprevention trials for breast, colon, and prostate cancer," Journal of Cellular Biochemistry 19:61, 1994 (National Cancer Insitute Symposium)
13. "Early detection and monitoring of cancer with the Anti-Malignin Antibody Test," Cancer Detection and Prevention 18(1):65-78, 1994
14. "A checklist for suitability of biomarkers as surrogate endpoints in chemoprecention breast cancer," Journal of Cellular Biochemistry 19:172-185, 1993 (National Cancer Institute Symposium
15. "Aglyco pathology of viral receptors in dementias. In functional diversity of interacting receptors" New York Academy of Sciences 757:413-417, 1995
16. "Return of elevated antimalignin antibody to normal indicates remission of breast cancer" American Association for Cancer Research 37:486, 1996
17. "Antimalignin Antibody (AMAS) elevation detects persistent or recurrent breast cancer" Cancer Detection and Prevention 20(5):508-509, 1996
18. "A new era for cancer diagonsis and treatment based upon earlier, asympotmatic detection" Journal of Adv. Med. 10:149-150, 1997
19. "Production of a sythetic general cancer vaccine which augments the concentration of antimalignin antibody in vivo" Cancer Detection and Prevention 22(1):S-227, 1998
20. "A quantitive immune response in human cancer" Cancer Det. and Prev. 22(1)S-159, 1998
21. "Anti-malignin antibody in serum and other tumor marker determinations in breast cancer" Cancer Letters 148:39-48, 2000
22. "Hepatitis B and C virus-associated malignant transformation in human liver (viral 'safe haven') produces a cytotoxic antimalignin immune response" Cancer Det. and Prev. (1):S156, 2000
23. "Antimalignin antibody in serum elevation precedes CA125 elevation in ovarian cancer and PSA elevation in prostate cacner, with both fewer false negatives and false positives" Cancer Det. and Prev.
24(1): S-162, 2000 24 Cancer Detection and Prevention 26(1):S, 2002
